Suppr超能文献

miR-1 和 miR-200 通过 Slug 依赖性和 Slug 非依赖性机制抑制 EMT 并促进肿瘤发生。

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.

机构信息

Cell and Cancer Biology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Oncogene. 2013 Jan 17;32(3):296-306. doi: 10.1038/onc.2012.58. Epub 2012 Feb 27.

Abstract

Epithelial-mesenchymal transition (EMT) is a developmental program of signaling pathways that determine commitment to epithelial and mesenchymal phenotypes. In the prostate, EMT processes have been implicated in benign prostatic hyperplasia and prostate cancer progression. In a model of Pten- and TP53-null prostate adenocarcinoma that progresses via transforming growth factor β-induced EMT, mesenchymal transformation is characterized by plasticity, leading to various mesenchymal lineages and the production of bone. Here we show that SLUG is a major regulator of mesenchymal differentiation. As microRNAs (miRs) are pleiotropic regulators of differentiation and tumorigenesis, we evaluated miR expression associated with tumorigenesis and EMT. Mir-1 and miR-200 were reduced with progression of prostate adenocarcinoma, and we identify Slug as one of the phylogenetically conserved targets of these miRs. We demonstrate that SLUG is a direct repressor of miR-1 and miR-200 transcription. Thus, SLUG and miR-1/miR-200 act in a self-reinforcing regulatory loop, leading to amplification of EMT. Depletion of Slug inhibited EMT during tumorigenesis, whereas forced expression of miR-1 or miR-200 inhibited both EMT and tumorigenesis in human and mouse model systems. Various miR targets were analyzed, and our findings suggest that miR-1 has roles in regulating EMT and mesenchymal differentiation through Slug and functions in tumor-suppressive programs by regulating additional targets.

摘要

上皮-间充质转化 (EMT) 是信号通路的发育程序,决定了上皮和间充质表型的承诺。在前列腺中,EMT 过程被牵连在良性前列腺增生和前列腺癌进展中。在 Pten 和 TP53 缺失的前列腺腺癌模型中,通过转化生长因子β诱导的 EMT 进展,间充质转化的特点是可塑性,导致各种间充质谱系和骨的产生。在这里,我们表明 SLUG 是间充质分化的主要调节剂。由于 microRNAs (miRs) 是分化和肿瘤发生的多效调节剂,我们评估了与肿瘤发生和 EMT 相关的 miR 表达。随着前列腺腺癌的进展,miR-1 和 miR-200 减少,我们确定 Slug 是这些 miR 的保守靶标之一。我们证明 SLUG 是 miR-1 和 miR-200 转录的直接抑制剂。因此,SLUG 和 miR-1/miR-200 作用于自我强化的调节环,导致 EMT 的放大。Slug 的耗竭抑制了肿瘤发生过程中的 EMT,而 miR-1 或 miR-200 的强制表达抑制了人类和小鼠模型系统中的 EMT 和肿瘤发生。分析了各种 miR 靶标,我们的研究结果表明,miR-1 通过 Slug 在调节 EMT 和间充质分化中发挥作用,并通过调节其他靶标在肿瘤抑制程序中发挥作用。

相似文献

1
MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms.
Oncogene. 2013 Jan 17;32(3):296-306. doi: 10.1038/onc.2012.58. Epub 2012 Feb 27.
3
Oncofetal H19 RNA promotes tumor metastasis.
Biochim Biophys Acta. 2014 Jul;1843(7):1414-26. doi: 10.1016/j.bbamcr.2014.03.023. Epub 2014 Apr 2.
4
Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
Cancer Sci. 2013 Dec;104(12):1609-17. doi: 10.1111/cas.12291. Epub 2013 Oct 27.
6
microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Am J Physiol Gastrointest Liver Physiol. 2019 Aug 1;317(2):G147-G160. doi: 10.1152/ajpgi.00284.2018. Epub 2019 Apr 3.
7
MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells.
Int J Oncol. 2014 Sep;45(3):1225-31. doi: 10.3892/ijo.2014.2506. Epub 2014 Jun 19.
9
Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
Gene. 2020 Mar 10;730:144264. doi: 10.1016/j.gene.2019.144264. Epub 2019 Nov 21.

引用本文的文献

2
Global research landscape and emerging trends of non-coding RNAs in prostate cancer: a bibliometric analysis.
Front Pharmacol. 2025 Jan 7;15:1483186. doi: 10.3389/fphar.2024.1483186. eCollection 2024.
3
Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications.
Int J Mol Sci. 2024 Dec 26;26(1):127. doi: 10.3390/ijms26010127.
4
The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.
J Biol Chem. 2024 Dec;300(12):107994. doi: 10.1016/j.jbc.2024.107994. Epub 2024 Nov 14.
6
Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance.
Int J Mol Sci. 2024 Apr 13;25(8):4306. doi: 10.3390/ijms25084306.
7
Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.
Cancers (Basel). 2024 Feb 27;16(5):956. doi: 10.3390/cancers16050956.
8
Epithelial-Mesenchymal Transition in Acute Leukemias.
Int J Mol Sci. 2024 Feb 11;25(4):2173. doi: 10.3390/ijms25042173.
10

本文引用的文献

2
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
Cancer Res. 2011 Dec 1;71(23):7301-11. doi: 10.1158/0008-5472.CAN-11-2381. Epub 2011 Oct 6.
4
Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
Cancer Res. 2011 Sep 1;71(17):5646-58. doi: 10.1158/0008-5472.CAN-11-1076. Epub 2011 Jul 6.
5
Prostate epithelial Pten/TP53 loss leads to transformation of multipotential progenitors and epithelial to mesenchymal transition.
Am J Pathol. 2011 Jul;179(1):422-35. doi: 10.1016/j.ajpath.2011.03.035. Epub 2011 May 13.
6
Role of Slug transcription factor in human mesenchymal stem cells.
J Cell Mol Med. 2012 Apr;16(4):740-51. doi: 10.1111/j.1582-4934.2011.01352.x.
7
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.
Nat Cell Biol. 2011 Mar;13(3):317-23. doi: 10.1038/ncb2173. Epub 2011 Feb 20.
8
Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 2011 Jan 1;71(1):245-54. doi: 10.1158/0008-5472.CAN-10-2330.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验